AUSTIN (November 27, 2012)--The Texas Attorney General's Office said Tuesday it has resolved its case against a Dallas-based mail-order compounding pharmacy over a shipment of a misbranded drug ingredient that led to three deaths in the Pacific Northwest.
A statement from the office Tuesday says pharmacist Gary Osborn and his companies, Apothecure Inc. and SpectraPharm Inc., will pay $200,000 to the state, including $100,000 in civil penalties and will also agree to compound drugs to order and in a legal manner.
Osborn and ApotheCure received probation and $100,000 fines after pleading guilty to two misdemeanor criminal violations of the federal Food, Drug and Cosmetic Act.
The cases center on a February 2007 shipment of a gout drug containing some vials with dosages more than seven times stronger than shown on the label.
Autopsies showed three Oregon patients suffered fatal overdoses.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.